🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial is studying how well tandutinib works in treating patie...
Status
Completed
Location
Case Western Reserve University
Start Date
2006-11
Trial ID
NCT00408902
Treatments Being Tested
Background: In order to survive, brain tumors must have a network of blood...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2008-04
Trial ID
NCT00667394
Treatments Being Tested
Prospective, nonrandomized, noncomparative, open-label, multicenter, 2-stag...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00297921
Treatments Being Tested
This is the first study of the drug CT53518 when given to humans. The purpo...
Status
Completed
Location
UCLA Medical Center
Start Date
2002-05
Trial ID
NCT00064584
Treatments Being Tested
This is a safety study of tandutinib in combination with temozolomide and b...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00904852
Treatments Being Tested
RATIONALE: Tandutinib may stop the growth of tumor cells by blocking some o...
Status
Completed
Location
M. D. Anderson Cancer Center at University of Texas
Start Date
2006-10
Trial ID
NCT00390468
Treatments Being Tested
This is a phase 1, open-label, multicenter study investigating the use of M...
Status
Completed
Location
The Dana Farber Cancer Institute
Start Date
2005-03
Trial ID
NCT00274248
Treatments Being Tested
This phase I/II trial is studying the side effects and best dose of tanduti...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2007-01
Trial ID
NCT00379080
Treatments Being Tested